Non Small Cell Lung Cancer Metastatic Clinical Trials

ReadTheTrial indexes 2 studies for Non Small Cell Lung Cancer Metastatic. The most common development stage is Phase 2 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Non Small Cell Lung Cancer Metastatic.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials for Non Small Cell Lung Cancer Metastatic

A Single-arm, Multicenter, Phase 2 Study of High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis

NCT06812871 · COMPLETED · Phase 2

HERTHENA-Lung01: A Phase 2 Randomized Open-Label Study of Patritumab Deruxtecan (U3-1402) in Subjects With Previously Treated Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)

NCT04619004 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Non Small Cell Lung Cancer Metastatic?

There are 2 clinical trials listed for Non Small Cell Lung Cancer Metastatic. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Non Small Cell Lung Cancer Metastatic trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Non Small Cell Lung Cancer Metastatic trials in?

Current Non Small Cell Lung Cancer Metastatic trials are distributed across: Phase 2 (2).

Find More Trials